Search for: "GenVec"
GenVec Announces Resignation of Mark Thornton as Senior Vice President, Product Development
HSMN NewsFeed,
19 May 2010:
Biopharmaceuticals, Personnel
[GenVec]
|
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
HSMN NewsFeed,
29 Jul 2009:
Biopharmaceuticals, Personnel
[Marinus Pharmaceuticals]
|
GenVec Reduces Costs to Preserve Capital
HSMN NewsFeed,
29 Jan 2009:
Biopharmaceuticals, Oncology
[GenVec, TNFerade]
|
GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade in Locally Advanced Pancreatic Cancer
HSMN NewsFeed,
19 Nov 2008:
Biopharmaceuticals, Oncology
[GenVec, TNFerade, pancreatic cancer]
|
TNFerade(TM) Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer
HSMN NewsFeed,
11 Nov 2008:
Biopharmaceuticals, Oncology, FDA
[GenVec, TNFerade, pancreatic cancer, fast track designation]
|
BIND Biosciences, Inc. Closes $16M Series B Financing Round
HSMN NewsFeed,
27 Nov 2007:
Biopharmaceuticals, Venture Capital
[BIND Biosciences]
|
Allozyne, Inc., Closes $30 Million Series B Financing and Appoints Meenu Chhabra as President and Chief Executive Officer
HSMN NewsFeed,
26 Oct 2007:
Biopharmaceuticals, Venture Capital, Personnel
[Allozyne, Multiple Sclerosis]
|
Advanced Cell Technology Completes Acquisition of Mytogen, Inc.
HSMN NewsFeed,
24 Sep 2007:
Regenerative Medicine, Mergers & Acquisitions
[Advanced Cell Technology, Mytogen, stem cell]
|
Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc.
HSMN NewsFeed,
1 Aug 2007:
Regenerative Medicine, Mergers & Acquisitions
[Advanced Cell Technology, Mytogen]
|
GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade(TM) at ASCO
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Oncology
[GenVec, TNFerade, gastrointestinal cancer]
|
Anaptys Biosciences Names Former Xoma Executive as Chairman and CEO
HSMN NewsFeed,
30 Apr 2007:
Biopharmaceuticals, Personnel
[Anaptys Biosciences, Tom Smart]
|
Alba Therapeutics Announces Appointment of Chief Financial Officer
HSMN NewsFeed,
16 Apr 2007:
Biopharmaceuticals, Personnel
[Alba Therapeutics]
|
Synta Pharmaceuticals Corp. Strengthens Oncology Clinical and Commercial Team
HSMN NewsFeed,
12 Apr 2007:
Biopharmaceuticals, Personnel
[Synta Pharmaceuticals]
|
Artisan Pharma, Inc. Hires Senior Clinical and Regulatory Management
HSMN NewsFeed,
26 Feb 2007:
Biopharmaceuticals, Personnel
[Artisan Pharma]
|
GenVec Announces First Patient Treated with TNFerade(TM) for Head and Neck Cancer at University of Chicago
HSMN NewsFeed,
26 Jan 2007:
Biopharmaceuticals, Oncology
[GenVec, TNFerade, head and neck cancer]
|
GenVec Receives Clearance From FDA for EUS Administration of TNFerade(TM)
HSMN NewsFeed,
11 Jan 2007:
Biopharmaceuticals, Oncology, FDA, Drug Delivery
[GenVec, TNFerade, pancreatic cancer, endoscopic ultrasound administration]
|
GenVec Announces Efficacy Update in Phase II/III Clinical Trial of TNFerade(TM) in Locally Advanced Pancreatic Cancer
HSMN NewsFeed,
19 Dec 2006:
Biopharmaceuticals, Oncology
[GenVec, TNFerade, pancreatic cancer]
|
GenVec Announces Completion of Interim Safety Data Analysis for Phase II/III Trial with TNFerade(TM) in Pancreatic Cancer
HSMN NewsFeed,
14 Dec 2006:
Biopharmaceuticals, Oncology
[GenVec, TNFerade, tumor necrosis factor, pancreatic cancer]
|
Symphogen Appoints Christian Meyer Vice President of Clinical Development
HSMN NewsFeed,
7 Nov 2006:
Biopharmaceuticals, Personnel
[Symphogen]
|
GenVec Names Mark O. Thornton, MD, MPH, PhD as Senior Vice President, Clinical Development
HSMN NewsFeed,
9 Oct 2006:
Biopharmaceuticals, Personnel
[GenVec]
|
GenVec Names Douglas J. Swirsky as Chief Financial Officer
HSMN NewsFeed,
19 Sep 2006:
Biopharmaceuticals, Personnel
[GenVec]
|
Stelios Papadopoulos to Resign from GenVec's Board of Directors
HSMN NewsFeed,
8 Sep 2006:
Biopharmaceuticals, Personnel
[GenVec]
|
Sapphire Therapeutics, Inc. Expands Drug Development Team
HSMN NewsFeed,
25 Aug 2006:
Biopharmaceuticals, Personnel
[Sapphire Therapeutics]
|
GenVec Vaccine Technology Enters First HIV Human Therapeutic Clinical Trials at Vaccine Research Center at NIH
HSMN NewsFeed,
22 Aug 2006:
Biopharmaceuticals, HIV/AIDS
[GenVec, HIV vaccine]
|
Novavax Names Jeffrey Church Chief Financial Officer
HSMN NewsFeed,
17 Aug 2006:
Biopharmaceuticals, Personnel
[Novavax]
|
GenVec Announces Resignation of Jeffrey W. Church as Chief Financial Officer
HSMN NewsFeed,
15 Aug 2006:
Biopharmaceuticals, Personnel
[GenVec]
|
Celldex appoints Thomas Davis, M.D as Chief Medical Officer and Tibor Keler, Ph.D as Chief Scientific Officer
HSMN NewsFeed,
25 May 2006:
Biopharmaceuticals, Personnel
[Celldex Therapeutics]
|
Long-Term Results from TNFerade(TM) Pancreatic Cancer Study and Updated Survival Results from TNFerade(TM) Esophageal Cancer Study Both Reported at Digestive Disease Week
HSMN NewsFeed,
23 May 2006:
Biopharmaceuticals, Oncology
[GenVec, TNFerade, esophageal cancer]
|
GenVec Appoints New Head of Clinical Operations
HSMN NewsFeed,
19 Apr 2006:
Biopharmaceuticals, Personnel
[GenVec]
|
GenVec Begins Phase II Melanoma Study with TNFerade(TM)
HSMN NewsFeed,
29 Mar 2006:
Biopharmaceuticals, Oncology
[GenVec, TNFerade, metastatic melanoma]
|
GenVec Names Russell Wesdyk Vice President of Business Development and Strategic Planning
HSMN NewsFeed,
14 Feb 2006:
Biopharmaceuticals, Personnel
[GenVec]
|
Long-Term Survival Data from Genvec's Phase II Study of TNFerade(TM) in Esophageal Cancer Presented at ASCO GI
HSMN NewsFeed,
27 Jan 2006:
Biopharmaceuticals, Oncology
[GenVec, TNFerade, Esophageal cancer]
|
Sapphire Therapeutics, Inc. Appoints New Director and Scientific Advisory Board to Support Oncologic and Metabolic Pipeline Development
HSMN NewsFeed,
17 Jan 2006:
Biopharmaceuticals, Personnel
[Sapphire Therapeutics]
|
|
|
Public
Feeds 
Full text >>
